Exchange: NASDAQ·Updated 06:37 AM EDT
News
all
press releases
Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell?
Key PointsModerna and Merck recently announced positive results from a late-stage clinical study of their melanoma treatment...
Nasdaq News: Markets
More News
Is It Too Late to Buy Moderna Stock After Its 127% Surge?
Key PointsModerna has made an incredible comeback, surging sixfold over the past year and by around 127% over the past few weeks...
Nasdaq News: Markets
CDC Reports COVID-19 Activity Is Increasing Across US
CDC Reports COVID-19 Activity Is Increasing Across US The Centers for Disease Control and Prevention on Friday said COVID-19 activity is "increasing" across the United States although its levels are still considered "very low" overall. "As of August 26, 2026, we estimate that...
Zero Hedge
'This Breakup Saved You Far More Than Moderna Ever Could': Orman to Woman Dumped After 180% Spike
'This Breakup Saved You Far More Than Moderna Ever Could': Orman to Woman Dumped After 180% Spike...
Yahoo! Finance: News
FDA Approves 3 New COVID-19 Vaccines
FDA Approves 3 New COVID-19 Vaccines Authored by Zachary Stieber via The Epoch Times, The Food and Drug Administration on Aug. 27 approved COVID-19 vaccines from Pfizer, Moderna, and Sanofi. A nurse prepares to give a COVID-19 vaccine to a child in Denver, Colo., on Nov. 3, 2021...
Zero Hedge
BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt — BMO Capital Terms It ‘Clear Setback’
BioNTech said on Friday that it and its partner, Genentech, a Roche unit, are ending the mid-stage study of autogene cevumeran, used alone after surgery, in certain high-risk stage II or III colorectal cancer patients.
Stocktwits
This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Wall Street analysts upgraded Moderna Inc and Evolution Petroleum Corp, and raised Enbridge's price target. Check out analysts' views on MRNA stock.read more...
Benzinga
Moderna Stock Falls 6% On Announcement Of $2.6 Bln Private Offering Of Convertible Senior Notes
(RTTNews) - Shares of Moderna, Inc. (MRNA) are falling around 6 percent on Friday morning after the company announced pricing of a $2.6 billion private offering of Convertible Senior Notes due 2032...
Nasdaq News: Markets
Moderna Stock Falls Friday: What's Going On?
Shares of Moderna are trading lower Friday morning after the company announced official terms for a major private debt offering.read more...
Benzinga
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax
FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.read more...
Benzinga

Advertisement|Remove ads.